Trade in substandard and falsified medicines

Trade in substandard and falsified medicines

According to WHO, 10.5% of medicines in low- and middle-income countries are substandard or falsified (SF), which has a multidimensional impact on public health as well as severe economic and socioeconomic consequences. Constrained access, weak technical capacity and poor governance contribute to th...

Полное описание

Библиографические подробности
Главные авторы:	Hagen, N, Hauk, C, Heide, L
Другие авторы:	Brombacher, D
Формат:	Book section
Язык:	English
Опубликовано:	Nomos 2022

Схожие документы

Identification of substandard and falsified medicines: influence of different tolerance limits and use of authenticity inquiries
по: Hauk, C, и др.
Опубликовано: (2021)

Substandard and Falsified Medicines in Myanmar
по: Mirai Sakuda, и др.
Опубликовано: (2020-03-01)

The uncertain role of substandard and falsified medicines in the emergence and spread of antimicrobial resistance
по: Cavany, S, и др.
Опубликовано: (2023)

The uncertain role of substandard and falsified medicines in the emergence and spread of antimicrobial resistance
по: Sean Cavany, и др.
Опубликовано: (2023-10-01)

How to achieve international action on falsified and substandard medicines.
по: Attaran, A, и др.
Опубликовано: (2012)

The need for comprehensive and multidisciplinary training in substandard and falsified medicines for pharmacists
по: Veronika J Wirtz, и др.
Опубликовано: (2019-07-01)

Combatting substandard and falsified medicines: a view from Rwanda.
по: Agnes Binagwaho, и др.
Опубликовано: (2013-01-01)

Substandard, falsified and unregistered medicines in Latin America, 2017-2018
по: Robin Rojas-Cortés
Опубликовано: (2020-10-01)

Substandard and Falsified Medicines: Proposed Methods for Case Finding and Sentinel Surveillance
по: Elizabeth Pisani, и др.
Опубликовано: (2021-08-01)

Falsified and substandard medicines trafficking: A wakeup call for the African continent
по: Yusuf Hassan Wada, и др.
Опубликовано: (2022-06-01)

Combatting Substandard and Falsified Medicines: Public Awareness and Identification of Counterfeit Medications
по: Faris El-Dahiyat, и др.
Опубликовано: (2021-10-01)

Surveillance for falsified and substandard medicines in Africa and Asia by local organizations using the low-cost GPHF Minilab.
по: Albert Petersen, и др.
Опубликовано: (2017-01-01)

Substandard and falsified antibiotics: neglected drivers of antimicrobial resistance?
по: Paul N Newton, и др.
Опубликовано: (2022-08-01)

Substandard and falsified antibiotics: neglected drivers of antimicrobial resistance?
по: Zabala, GA, и др.
Опубликовано: (2022)

Tackling the global impact of substandard and falsified and unregistered/unlicensed anti-tuberculosis medicines
по: Tamara Akpobolokemi, и др.
Опубликовано: (2022-01-01)

The economic impact of substandard and falsified antimalarial medications in Nigeria.
по: Sarah M Beargie, и др.
Опубликовано: (2019-01-01)

The Future of Falsified and Substandard Medicine Detection: Digital Methods To Track and Authenticate Pharmaceutical Products
по: Naughton, B
Опубликовано: (2018)

A random survey of the prevalence of falsified and substandard antibiotics in the Lao PDR
по: Tabernero, P, и др.
Опубликовано: (2022)

A random survey of the prevalence of falsified and substandard antibiotics in the Lao PDR
по: Tabernero, P, и др.
Опубликовано: (2019)

Technologies for detecting falsified and substandard drugs in low and middle-income countries.
по: Stephanie Kovacs, и др.
Опубликовано: (2014-01-01)

Surveillance for substandard and falsified medicines by local faith-based organizations in 13 low- and middle-income countries using the GPHF Minilab
по: Gesa Gnegel, и др.
Опубликовано: (2022-07-01)

The concept of substandard (falsified and poor quality) industrial products and its types
по: K. A. Utarov, и др.
Опубликовано: (2022-09-01)

The concept of substandard (falsified and poor quality) industrial products and its types
по: K. A. Utarov, и др.
Опубликовано: (2022-09-01)

Substandard and falsified medical products: bibliometric analysis and mapping of scientific research
по: Waleed M. Sweileh
Опубликовано: (2021-09-01)

Mobile apps for detecting falsified and substandard drugs: A systematic review.
по: Agustín Ciapponi, и др.
Опубликовано: (2021-01-01)

Exploring pharmacists' perspectives about substandard and falsified medical products through interviews
по: A. Persson, и др.
Опубликовано: (2024-03-01)

Prevalence of substandard, falsified, unlicensed and unregistered medicine and its associated factors in Africa: a systematic review
по: Biset Asrade Mekonnen, и др.
Опубликовано: (2024-12-01)

Quantitative screening of the pharmaceutical ingredient for the rapid identification of substandard and falsified medicines using reflectance infrared spectroscopy.
по: Graham Lawson, и др.
Опубликовано: (2018-01-01)

A cross-sectional analysis of falsified, counterfeit and substandard medicines in a low-middle income country
по: Daariimaa Khurelbat, и др.
Опубликовано: (2020-05-01)

Substandard and falsified antimicrobials in selected east African countries: A systematic review.
по: Addisu Afrassa Tegegne, и др.
Опубликовано: (2024-01-01)

Substandard and falsified antimicrobials in selected east African countries: A systematic review
по: Addisu Afrassa Tegegne, и др.
Опубликовано: (2024-01-01)

Screening for substandard and falsified medicines in Nigeria using visual inspection and GPHF-Minilab analysis: lessons learnt for future training of health workers and pharmacy personnel
по: Micha Lächele, и др.
Опубликовано: (2024-12-01)

A systematic review of substandard, falsified, unlicensed and unregistered medicine sampling studies: a focus on context, prevalence, and quality
по: McManus, D, и др.
Опубликовано: (2020)

A systematic review of substandard, falsified, unlicensed and unregistered medicine sampling studies: a focus on context, prevalence, and quality
по: Dominic McManus, и др.
Опубликовано: (2020-08-01)

Unveiling the Peril of Substandard and Falsified Medicines to Public Health and Safety in Africa: Need for All-Out War to End the Menace
по: Nafiu Aminu, и др.
Опубликовано: (2017-01-01)

Comparing the return on investment of technologies to detect substandard and falsified amoxicillin: A Kenya case study.
по: Colleen R Higgins, и др.
Опубликовано: (2023-01-01)

Comparing the return on investment of technologies to detect substandard and falsified amoxicillin: A Kenya case study
по: Colleen R. Higgins, и др.
Опубликовано: (2023-01-01)

Small-scale dissolution test screening tool to select potentially substandard and falsified (SF) medicines requiring full pharmacopoeial analysis
по: Mohammad Sofiqur Rahman, и др.
Опубликовано: (2021-06-01)

Cost savings of paper analytical devices (PADs) to detect substandard and falsified antibiotics: Kenya case study
по: Hui-Han Chen, и др.
Опубликовано: (2021-03-01)

Substandard, Spurious, Falsely-Labelled, Falsified and Counterfeit (SSFFC) Drugs: Time to Take a Bitter Pill
по: Geetha Mani, и др.
Опубликовано: (2016-10-01)